• Je něco špatně v tomto záznamu ?

Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study

P. Dusek, E. Bahn, T. Litwin, K. Jabłonka-Salach, A. Łuciuk, T. Huelnhagen, VI. Madai, MA. Dieringer, E. Bulska, M. Knauth, T. Niendorf, J. Sobesky, F. Paul, SA. Schneider, A. Czlonkowska, W. Brück, C. Wegner, J. Wuerfel,

. 2017 ; 43 (6) : 514-532. [pub] 20161004

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025327

Grantová podpora
NV15-25602A MZ0 CEP - Centrální evidence projektů

AIMS: In Wilson disease (WD), T2/T2*-weighted (T2*w) MRI frequently shows hypointensity in the basal ganglia that is suggestive of paramagnetic deposits. It is currently unknown whether this hypointensity is related to copper or iron deposition. We examined the neuropathological correlates of this MRI pattern, particularly in relation to iron and copper concentrations. METHODS: Brain slices from nine WD and six control cases were investigated using a 7T-MRI system. High-resolution T2*w images were acquired and R2* parametric maps were reconstructed using a multigradient recalled echo sequence. R2* was measured in the globus pallidus (GP) and the putamen. Corresponding histopathological sections containing the lentiform nucleus were examined using Turnbull iron staining, and double staining combining Turnbull with immunohistochemistry for macrophages or astrocytes. Quantitative densitometry of the iron staining as well as copper and iron concentrations were measured in the GP and putamen and correlated with R2* values. RESULTS: T2*w hypointensity in the GP and/or putamen was apparent in WD cases and R2* values correlated with quantitative densitometry of iron staining. In WD, iron and copper concentrations were increased in the putamen compared to controls. R2* was correlated with the iron concentration in the GP and putamen, whereas no correlation was observed for the copper concentration. Patients with more pronounced pathological severity in the putamen displayed increased iron concentration, which correlated with an elevated number of iron-containing macrophages. CONCLUSIONS: T2/T2*w hypointensity observed in vivo in the basal ganglia of WD patients is related to iron rather than copper deposits.

2nd Department of Neurology Institute Psychiatry and Neurology Warsaw Poland

2nd Department of Neurology Institute Psychiatry and Neurology Warsaw Poland Department of Experimental and Clinical Pharmacology Medical University Warsaw Poland

Berlin Ultrahigh Field Facility Berlin Germany

Berlin Ultrahigh Field Facility Max Delbrück Center for Molecular Medicine in the Helmholtz Association Berlin Germany

Department of Neurology and Center for Stroke Research Berlin Berlin Germany

Department of Neurology and Center for Stroke Research Berlin Charité Universitätsmedizin Berlin Germany

Experimental and Clinical Research Center Berlin Germany NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center Department of Neurology Charité Universitätsmedizin Berlin Germany

Faculty of Chemistry Biological and Chemical Research Centre University of Warsaw Warsaw Poland

Institute of Neuropathology University Medical Center Göttingen Göttingen Germany

Institute of Neuroradiology University Medical Center Göttingen Göttingen Germany

Institute of Neuroradiology University Medical Center Göttingen Göttingen Germany Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine and General University Hospital Prague Charles University Prague Praha Czech Republic

Institute of Neuroradiology University Medical Center Göttingen Göttingen Germany NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center Department of Neurology Charité Universitätsmedizin Berlin Germany Medical Imaging Analysis Center AG Basel Switzerland

Neurology Department University of Kiel Kiel Germany Department of Neurology Ludwig Maximilians University Munich Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025327
003      
CZ-PrNML
005      
20180717102701.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/nan.12341 $2 doi
035    __
$a (PubMed)27543917
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dusek, P $u Institute of Neuroradiology, University Medical Center Göttingen, Göttingen, Germany. Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital in Prague, Charles University in Prague, Praha, Czech Republic.
245    10
$a Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study / $c P. Dusek, E. Bahn, T. Litwin, K. Jabłonka-Salach, A. Łuciuk, T. Huelnhagen, VI. Madai, MA. Dieringer, E. Bulska, M. Knauth, T. Niendorf, J. Sobesky, F. Paul, SA. Schneider, A. Czlonkowska, W. Brück, C. Wegner, J. Wuerfel,
520    9_
$a AIMS: In Wilson disease (WD), T2/T2*-weighted (T2*w) MRI frequently shows hypointensity in the basal ganglia that is suggestive of paramagnetic deposits. It is currently unknown whether this hypointensity is related to copper or iron deposition. We examined the neuropathological correlates of this MRI pattern, particularly in relation to iron and copper concentrations. METHODS: Brain slices from nine WD and six control cases were investigated using a 7T-MRI system. High-resolution T2*w images were acquired and R2* parametric maps were reconstructed using a multigradient recalled echo sequence. R2* was measured in the globus pallidus (GP) and the putamen. Corresponding histopathological sections containing the lentiform nucleus were examined using Turnbull iron staining, and double staining combining Turnbull with immunohistochemistry for macrophages or astrocytes. Quantitative densitometry of the iron staining as well as copper and iron concentrations were measured in the GP and putamen and correlated with R2* values. RESULTS: T2*w hypointensity in the GP and/or putamen was apparent in WD cases and R2* values correlated with quantitative densitometry of iron staining. In WD, iron and copper concentrations were increased in the putamen compared to controls. R2* was correlated with the iron concentration in the GP and putamen, whereas no correlation was observed for the copper concentration. Patients with more pronounced pathological severity in the putamen displayed increased iron concentration, which correlated with an elevated number of iron-containing macrophages. CONCLUSIONS: T2/T2*w hypointensity observed in vivo in the basal ganglia of WD patients is related to iron rather than copper deposits.
650    _2
$a dospělí $7 D000328
650    _2
$a astrocyty $7 D001253
650    _2
$a bazální ganglia $x diagnostické zobrazování $x metabolismus $x patologie $7 D001479
650    _2
$a měď $x metabolismus $7 D003300
650    _2
$a corpus striatum $x metabolismus $x patologie $7 D003342
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepatolentikulární degenerace $x diagnostické zobrazování $x metabolismus $x patologie $7 D006527
650    _2
$a lidé $7 D006801
650    _2
$a železo $x metabolismus $7 D007501
650    _2
$a makrofágy $7 D008264
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bahn, E $u Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
700    1_
$a Litwin, T $u 2nd Department of Neurology, Institute Psychiatry and Neurology, Warsaw, Poland.
700    1_
$a Jabłonka-Salach, K $u Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.
700    1_
$a Łuciuk, A $u Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.
700    1_
$a Huelnhagen, T $u Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
700    1_
$a Madai, V I $u Department of Neurology and Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin, Berlin, Germany.
700    1_
$a Dieringer, M A $u Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin and Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany.
700    1_
$a Bulska, E $u Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.
700    1_
$a Knauth, M $u Institute of Neuroradiology, University Medical Center Göttingen, Göttingen, Germany.
700    1_
$a Niendorf, T $u Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin and Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany.
700    1_
$a Sobesky, J $u Department of Neurology and Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin, Berlin, Germany. Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin and Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany.
700    1_
$a Paul, F $u Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin and Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany. NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité-Universitätsmedizin, Berlin, Germany.
700    1_
$a Schneider, S A $u Neurology Department, University of Kiel, Kiel, Germany. Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
700    1_
$a Czlonkowska, A $u 2nd Department of Neurology, Institute Psychiatry and Neurology, Warsaw, Poland. Department of Experimental and Clinical Pharmacology, Medical University, Warsaw, Poland.
700    1_
$a Brück, W $u Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
700    1_
$a Wegner, C $u Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
700    1_
$a Wuerfel, J $u Institute of Neuroradiology, University Medical Center Göttingen, Göttingen, Germany. NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité-Universitätsmedizin, Berlin, Germany. Medical Imaging Analysis Center AG, Basel, Switzerland.
773    0_
$w MED00003495 $t Neuropathology and applied neurobiology $x 1365-2990 $g Roč. 43, č. 6 (2017), s. 514-532
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27543917 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180717103000 $b ABA008
999    __
$a ok $b bmc $g 1317458 $s 1022248
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 43 $c 6 $d 514-532 $e 20161004 $i 1365-2990 $m Neuropathology and applied neurobiology $n Neuropathol Appl Neurobiol $x MED00003495
GRA    __
$a NV15-25602A $p MZ0
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace